{"id":12401,"date":"2021-03-11T21:08:40","date_gmt":"2021-03-12T02:08:40","guid":{"rendered":"https:\/\/www.progeriaresearch.org\/?p=12401"},"modified":"2022-11-14T17:12:14","modified_gmt":"2022-11-14T22:12:14","slug":"exciting-breakthroughs-in-rna-therapeutics-for-progeria","status":"publish","type":"post","link":"https:\/\/www.progeriaresearch.org\/ur\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/","title":{"rendered":"\u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u0639\u0644\u0627\u062c \u0645\u06cc\u06ba \u062f\u0644\u0686\u0633\u067e \u067e\u06cc\u0634 \u0631\u0641\u062a!"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

\"\"<\/p>\n

\u06c1\u0645 \u0633\u06d2 \u0646\u062a\u0627\u0626\u062c \u0628\u0627\u0646\u0679 \u06a9\u0631 \u0628\u06c1\u062a \u067e\u0631\u062c\u0648\u0634 \u06c1\u06cc\u06ba\u06d4 \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0627\u0633\u062a\u0639\u0645\u0627\u0644 \u067e\u0631 \u062f\u0648 \u0628\u06c1\u062a \u06c1\u06cc \u062f\u0644\u0686\u0633\u067e \u067e\u06cc\u0634 \u0631\u0641\u062a \u0645\u0637\u0627\u0644\u0639\u0627\u062a<\/strong> \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u06a9\u06cc \u062a\u062d\u0642\u06cc\u0642 \u0645\u06cc\u06ba\u06d4 \u062f\u0648\u0646\u0648\u06ba \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u06a9\u0648 \u062f\u06cc \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0631\u06cc\u0633\u0631\u0686 \u0641\u0627\u0624\u0646\u0688\u06cc\u0634\u0646 (PRF) \u06a9\u06d2 \u062a\u0639\u0627\u0648\u0646 \u0633\u06d2 \u0645\u0627\u0644\u06cc \u0627\u0639\u0627\u0646\u062a \u0641\u0631\u0627\u06c1\u0645 \u06a9\u06cc \u06af\u0626\u06cc \u062a\u06be\u06cc \u0627\u0648\u0631 PRF \u06a9\u06d2 \u0645\u06cc\u0688\u06cc\u06a9\u0644 \u0688\u0627\u0626\u0631\u06cc\u06a9\u0679\u0631 \u0688\u0627\u06a9\u0679\u0631 \u0644\u06cc\u0633\u0644\u06cc \u06af\u0648\u0631\u0688\u0646 \u0646\u06d2 \u0645\u0634\u062a\u0631\u06a9\u06c1 \u0637\u0648\u0631 \u067e\u0631 \u0644\u06a9\u06be\u0627 \u062a\u06be\u0627\u06d4<\/p>\n

\u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0645\u06cc\u06ba \u0628\u06cc\u0645\u0627\u0631\u06cc \u067e\u06cc\u062f\u0627 \u06a9\u0631\u0646\u06d2 \u0648\u0627\u0644\u0627 \u067e\u0631\u0648\u0679\u06cc\u0646 \u06c1\u06d2\u06d4 \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u06a9\u06d2 \u0639\u0644\u0627\u062c \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u06a9\u06cc \u0633\u0637\u062d \u067e\u0631 \u0627\u0633 \u06a9\u06cc \u067e\u06cc\u062f\u0627\u0648\u0627\u0631 \u06a9\u0648 \u0631\u0648\u06a9 \u06a9\u0631 \u062c\u0633\u0645 \u06a9\u06cc \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u067e\u06cc\u062f\u0627 \u06a9\u0631\u0646\u06d2 \u06a9\u06cc \u0635\u0644\u0627\u062d\u06cc\u062a \u0645\u06cc\u06ba \u0645\u062f\u0627\u062e\u0644\u062a \u06a9\u0631\u062a\u06d2 \u06c1\u06cc\u06ba\u06d4 \u0627\u0633 \u06a9\u0627 \u0645\u0637\u0644\u0628 \u06cc\u06c1 \u06c1\u06d2\u06d4 \u0639\u0644\u0627\u062c \u0632\u06cc\u0627\u062f\u06c1 \u062a\u0631 \u0639\u0644\u0627\u062c \u0633\u06d2 \u0632\u06cc\u0627\u062f\u06c1 \u0645\u062e\u0635\u0648\u0635 \u06c1\u06d2\u06d4<\/strong> \u062c\u0648 \u067e\u0631\u0648\u0679\u06cc\u0646 \u06a9\u06cc \u0633\u0637\u062d \u067e\u0631 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u06a9\u0648 \u0646\u0634\u0627\u0646\u06c1 \u0628\u0646\u0627\u062a\u0627 \u06c1\u06d2\u06d4<\/p>\n

\u0627\u06af\u0631\u0686\u06c1 \u06c1\u0631 \u0645\u0637\u0627\u0644\u0639\u06c1 \u0645\u06cc\u06ba \u062f\u0648\u0627\u0624\u06ba \u06a9\u06cc \u062a\u0631\u0633\u06cc\u0644 \u06a9\u06d2 \u0645\u062e\u062a\u0644\u0641 \u0646\u0638\u0627\u0645 \u06a9\u0627 \u0627\u0633\u062a\u0639\u0645\u0627\u0644 \u06a9\u06cc\u0627 \u06af\u06cc\u0627\u060c \u062f\u0648\u0646\u0648\u06ba \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u0646\u06d2 \u0627\u06cc\u06a9 \u06c1\u06cc \u0628\u0646\u06cc\u0627\u062f\u06cc \u0639\u0644\u0627\u062c \u06a9\u06cc \u062d\u06a9\u0645\u062a \u0639\u0645\u0644\u06cc \u06a9\u0648 \u0646\u0634\u0627\u0646\u06c1 \u0628\u0646\u0627\u06cc\u0627\u060c \u063a\u06cc\u0631 \u0645\u0639\u0645\u0648\u0644\u06cc \u067e\u0631\u0648\u0679\u06cc\u0646\u060c \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u06a9\u06d2 \u0644\u06cc\u06d2 RNA \u06a9\u0648\u0688\u0646\u06af \u06a9\u06cc \u067e\u06cc\u062f\u0627\u0648\u0627\u0631 \u06a9\u0648 \u0631\u0648\u06a9\u062a\u0627 \u06c1\u06d2\u06d4 \u062f\u0648\u0646\u0648\u06ba \u06a9\u06cc \u0642\u06cc\u0627\u062f\u062a \u0646\u06cc\u0634\u0646\u0644 \u0627\u0646\u0633\u0679\u06cc \u0679\u06cc\u0648\u0679 \u0622\u0641 \u06c1\u06cc\u0644\u062a\u06be (NIH) \u06a9\u06d2 \u0645\u062d\u0642\u0642\u06cc\u0646 \u06a9\u0631 \u0631\u06c1\u06d2 \u062a\u06be\u06d2\u060c \u0627\u0648\u0631 \u0622\u062c \u062c\u0631\u06cc\u062f\u06d2 \u0645\u06cc\u06ba \u0634\u0627\u0626\u0639 \u06c1\u0648\u0626\u06d2\u06d4 \u0646\u06cc\u0686\u0631 \u0645\u06cc\u0688\u06cc\u0633\u0646<\/em>.<\/p>\n

\u0627\u06cc\u06a9 \u0645\u0637\u0627\u0644\u0639\u06c1<\/a>\u0641\u0631\u0627\u0646\u0633\u0633 \u06a9\u0648\u0644\u0646\u0632\u060c \u0627\u06cc\u0645 \u0688\u06cc\u060c \u067e\u06cc \u0627\u06cc\u0686 \u0688\u06cc\u060c NIH \u06a9\u06d2 \u0688\u0627\u0626\u0631\u06cc\u06a9\u0679\u0631 \u06a9\u06cc \u0642\u06cc\u0627\u062f\u062a \u0645\u06cc\u06ba\u060c \u0646\u06d2 \u062f\u06a9\u06be\u0627\u06cc\u0627 \u06a9\u06c1 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0686\u0648\u06c1\u0648\u06ba \u06a9\u0627 \u0639\u0644\u0627\u062c SRP2001 \u0646\u0627\u0645\u06cc \u062f\u0648\u0627 \u0633\u06d2\u0634\u06c1 \u0631\u06af \u0645\u06cc\u06ba \u0646\u0642\u0635\u0627\u0646 \u062f\u06c1 progerin mRNA \u0627\u0648\u0631 \u067e\u0631\u0648\u0679\u06cc\u0646 \u06a9\u06d2 \u0627\u0638\u06c1\u0627\u0631 \u06a9\u06cc \u062a\u0639\u0644\u06cc\u0645 \u062f\u06cc\u06d4<\/strong>\u060c \u062c\u0633\u0645 \u0645\u06cc\u06ba \u0627\u06c1\u0645 \u0634\u0631\u06cc\u0627\u0646 \u06a9\u06d2 \u0633\u0627\u062a\u06be \u0633\u0627\u062a\u06be \u062f\u0648\u0633\u0631\u06d2 \u0679\u0634\u0648\u0632 \u0645\u06cc\u06ba\u06d4 \u0645\u0637\u0627\u0644\u0639\u06c1 \u06a9\u06d2 \u0627\u062e\u062a\u062a\u0627\u0645 \u067e\u0631\u060c \u0634\u06c1 \u0631\u06af \u06a9\u06cc \u062f\u06cc\u0648\u0627\u0631 \u0645\u0636\u0628\u0648\u0637 \u0631\u06c1\u06cc \u0627\u0648\u0631 \u0686\u0648\u06c1\u0648\u06ba \u0646\u06d2 \u0627\u06cc\u06a9 \u06a9\u0627 \u0645\u0638\u0627\u06c1\u0631\u06c1 \u06a9\u06cc\u0627\u06d4 60% \u0633\u06d2 \u0632\u06cc\u0627\u062f\u06c1 \u06a9\u06cc \u0628\u0642\u0627 \u0645\u06cc\u06ba \u0627\u0636\u0627\u0641\u06c1<\/strong>.<\/p>\n

\u06a9\u0648\u0644\u0646\u0632 \u0646\u06d2 \u06a9\u06c1\u0627 \u06a9\u06c1 "\u062d\u06cc\u0648\u0627\u0646\u0627\u062a \u06a9\u06d2 \u0645\u0627\u0688\u0644 \u0645\u06cc\u06ba \u0679\u0627\u0631\u06af\u0679\u0688 RNA-\u062a\u06be\u0631\u0627\u067e\u06cc \u06a9\u06d2 \u0627\u06cc\u0633\u06d2 \u0627\u06c1\u0645 \u0646\u062a\u0627\u0626\u062c \u062f\u06a9\u06be\u0627\u0646\u0627 \u0645\u062c\u06be\u06d2 \u0627\u0645\u06cc\u062f \u062f\u06cc\u062a\u0627 \u06c1\u06d2 \u06a9\u06c1 \u06cc\u06c1 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u06a9\u06d2 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0644\u06cc\u06d2 \u0627\u06cc\u06a9 \u0628\u0691\u06cc \u067e\u06cc\u0634 \u0631\u0641\u062a \u06a9\u0627 \u0628\u0627\u0639\u062b \u0628\u0646 \u0633\u06a9\u062a\u0627 \u06c1\u06d2\u06d4"<\/p>\n

\u062f\u06cc \u062f\u06cc\u06af\u0631 \u0645\u0637\u0627\u0644\u0639\u06c1<\/a>\u060c \u062c\u0633 \u06a9\u06cc \u0642\u06cc\u0627\u062f\u062a \u0679\u0627\u0645 \u0645\u06cc\u0633\u0679\u06cc\u0644\u06cc\u060c \u067e\u06cc \u0627\u06cc\u0686 \u0688\u06cc\u060c \u0633\u06cc\u0646\u0679\u0631 \u0641\u0627\u0631 \u06a9\u06cc\u0646\u0633\u0631 \u0631\u06cc\u0633\u0631\u0686\u060c \u0646\u06cc\u0634\u0646\u0644 \u06a9\u06cc\u0646\u0633\u0631 \u0627\u0646\u0633\u0679\u06cc \u0679\u06cc\u0648\u0679\u060c \u0627\u06cc\u0646 \u0622\u0626\u06cc \u0627\u06cc\u0686 \u06a9\u06d2 \u0688\u0627\u0626\u0631\u06cc\u06a9\u0679\u0631 \u0646\u06d2 \u06a9\u06cc\u060c \u0646\u06d2 \u062f\u06a9\u06be\u0627\u06cc\u0627\u06d4 90 - 95% \u0632\u06c1\u0631\u06cc\u0644\u06d2 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u067e\u06cc\u062f\u0627 \u06a9\u0631\u0646\u06d2 \u0648\u0627\u0644\u06d2 RNA \u06a9\u06cc \u06a9\u0645\u06cc<\/strong> LB143 \u0646\u0627\u0645\u06cc \u062f\u0648\u0627 \u06a9\u06d2 \u0633\u0627\u062a\u06be \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0628\u0639\u062f \u0645\u062e\u062a\u0644\u0641 \u0679\u0634\u0648\u0632 \u0645\u06cc\u06ba\u06d4 \u0645\u0633\u0679\u06cc\u0644\u06cc \u06a9\u06cc \u0644\u06cc\u0628 \u0646\u06d2 \u067e\u0627\u06cc\u0627 \u06a9\u06c1 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u067e\u0631\u0648\u0679\u06cc\u0646 \u06a9\u06cc \u06a9\u0645\u06cc \u062c\u06af\u0631 \u0645\u06cc\u06ba \u0633\u0628 \u0633\u06d2 \u0632\u06cc\u0627\u062f\u06c1 \u0645\u0648\u062b\u0631 \u062a\u06be\u06cc\u060c \u062f\u0644 \u0627\u0648\u0631 \u0634\u06c1 \u0631\u06af \u0645\u06cc\u06ba \u0627\u0636\u0627\u0641\u06cc \u0628\u06c1\u062a\u0631\u06cc \u06a9\u06d2 \u0633\u0627\u062a\u06be\u06d4<\/p>\n

\u0627\u0628 \u06c1\u0645 \u062c\u0627\u0646\u062a\u06d2 \u06c1\u06cc\u06ba \u06a9\u06c1 RNA \u0639\u0644\u0627\u062c \u06a9\u0627 \u0627\u0633\u062a\u0639\u0645\u0627\u0644 \u06a9\u0631\u062a\u06d2 \u06c1\u0648\u0626\u06d2 \u0646\u0642\u0635\u0627\u0646 \u062f\u06c1 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u067e\u0631\u0648\u0679\u06cc\u0646 \u06a9\u06cc \u067e\u06cc\u062f\u0627\u0648\u0627\u0631 \u06a9\u0648 \u06a9\u0645 \u06a9\u0631\u0646\u06d2 \u06a9\u06d2 \u0645\u062a\u0639\u062f\u062f \u0637\u0631\u06cc\u0642\u06d2 \u06c1\u06cc\u06ba\u06d4 \u06c1\u0631 \u0645\u0637\u0627\u0644\u0639\u06c1 \u0646\u06d2 \u0645\u0627\u0624\u0633 \u0645\u0627\u0688\u0644\u0632 \u0645\u06cc\u06ba \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u06a9\u06d2 \u0645\u062e\u062a\u0644\u0641 \u062d\u0635\u0648\u06ba \u06a9\u0648 \u067e\u0627\u06cc\u0627 \u062c\u0648\u060c \u062c\u0628 \u0646\u0634\u0627\u0646\u06c1 \u0628\u0646\u0627\u06cc\u0627 \u062c\u0627\u062a\u0627 \u06c1\u06d2\u060c \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0644\u06cc\u06d2 \u0627\u06cc\u06a9 \u0645\u0624\u062b\u0631 \u0631\u0627\u0633\u062a\u06c1 \u0641\u0631\u0627\u06c1\u0645 \u06a9\u0631\u062a\u0627 \u06c1\u06d2\u060c \u062c\u0633 \u06a9\u06d2 \u0646\u062a\u06cc\u062c\u06d2 \u0645\u06cc\u06ba \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0686\u0648\u06c1\u06d2 \u062c\u0648 \u0644\u0648\u0646\u0627\u0641\u0627\u0631\u0646\u06cc\u0628 \u06a9\u06d2 \u0633\u0627\u062a\u06be \u067e\u0686\u06be\u0644\u06d2 \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u0645\u06cc\u06ba \u0639\u0644\u0627\u062c \u06a9\u06cc\u06d2 \u06af\u0626\u06d2 \u0627\u0646 \u0633\u06d2 \u06a9\u06c1\u06cc\u06ba \u0632\u06cc\u0627\u062f\u06c1 \u0632\u0646\u062f\u06c1 \u0631\u06c1\u06d2\u06d4<\/strong>\u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0648\u0627\u0644\u06d2 \u0628\u0686\u0648\u06ba \u06a9\u06d2 \u0644\u06cc\u06d2 \u0648\u0627\u062d\u062f FDA \u0633\u06d2 \u0645\u0646\u0638\u0648\u0631 \u0634\u062f\u06c1 \u062f\u0648\u0627\u06d4 \u0645\u0632\u06cc\u062f \u0628\u0631\u0622\u06ba\u060c \u0645\u062d\u0642\u0642\u06cc\u0646 \u0646\u06d2 \u067e\u0627\u06cc\u0627 \u06a9\u06c1 \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u0639\u0644\u0627\u062c \u0627\u0648\u0631 \u0644\u0648\u0646\u0627\u0641\u0627\u0631\u0646\u06cc\u0628 \u06a9\u06d2 \u0633\u0627\u062a\u06be \u0645\u0634\u062a\u0631\u06a9\u06c1 \u0639\u0644\u0627\u062c \u0646\u06d2 \u062c\u06af\u0631 \u0627\u0648\u0631 \u062f\u0644 \u0645\u06cc\u06ba \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0646 \u067e\u0631\u0648\u0679\u06cc\u0646 \u06a9\u06cc \u0633\u0637\u062d \u06a9\u0648 \u0627\u067e\u0646\u06d2 \u0637\u0648\u0631 \u067e\u0631 \u06a9\u0633\u06cc \u0627\u06cc\u06a9 \u0639\u0644\u0627\u062c \u0633\u06d2 \u0632\u06cc\u0627\u062f\u06c1 \u0645\u0624\u062b\u0631 \u0637\u0631\u06cc\u0642\u06d2 \u0633\u06d2 \u06a9\u0645 \u06a9\u06cc\u0627\u06d4<\/p>\n

"\u06cc\u06c1 \u062f\u0648 \u0627\u0646\u062a\u06c1\u0627\u0626\u06cc \u0627\u06c1\u0645 \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u0627\u0633 \u0628\u0627\u062a \u06a9\u0648 \u0638\u0627\u06c1\u0631 \u06a9\u0631\u062a\u06d2 \u06c1\u06cc\u06ba\u06d4 \u0627\u06c1\u0645 \u067e\u06cc\u0634\u0631\u0641\u062a \u062c\u0648 \u0627\u0628 \u06c1\u0645 \u067e\u0631 \u06c1\u06cc\u06ba\u06d4<\/strong> \u0679\u0627\u0631\u06af\u0679\u0688 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0634\u0639\u0628\u06d2 \u0645\u06cc\u06ba\u060c" PRF \u06a9\u06d2 \u0645\u06cc\u0688\u06cc\u06a9\u0644 \u0688\u0627\u0626\u0631\u06cc\u06a9\u0679\u0631\u060c \u0688\u0627\u06a9\u0679\u0631 \u0644\u06cc\u0633\u0644\u06cc \u06af\u0648\u0631\u0688\u0646 \u0646\u06d2 \u06a9\u06c1\u0627\u06d4 "\u0645\u06cc\u06ba \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0648\u0627\u0644\u06d2 \u0628\u0686\u0648\u06ba \u06a9\u06d2 \u0644\u06cc\u06d2 \u0622\u0631 \u0627\u06cc\u0646 \u0627\u06d2 \u062a\u06be\u0631\u0627\u067e\u06cc \u06a9\u0648 \u0622\u06af\u06d2 \u0628\u0691\u06be\u0627\u0646\u06d2 \u06a9\u06d2 \u0644\u06cc\u06d2 \u0627\u0646 \u0634\u0627\u0646\u062f\u0627\u0631 \u0631\u06cc\u0633\u0631\u0686 \u06af\u0631\u0648\u067e\u0648\u06ba \u06a9\u06d2 \u0633\u0627\u062a\u06be \u06a9\u0627\u0645 \u06a9\u0631\u0646\u06d2 \u067e\u0631 \u0628\u06c1\u062a \u062e\u0648\u0634 \u062a\u06be\u0627\u06d4 \u062f\u0648\u0646\u0648\u06ba \u06c1\u06cc \u062f\u0644\u0686\u0633\u067e \u062b\u0628\u0648\u062a \u06a9\u06d2 \u0627\u0635\u0648\u0644\u06cc \u0645\u0637\u0627\u0644\u0639\u06c1 \u06c1\u06cc\u06ba\u060c \u0627\u0648\u0631 PRF \u06a9\u0644\u06cc\u0646\u06cc\u06a9\u0644 \u0679\u0631\u0627\u0626\u0644\u0632 \u06a9\u06cc \u0637\u0631\u0641 \u0622\u06af\u06d2 \u0628\u0691\u06be\u0646\u06d2 \u06a9\u06d2 \u0644\u06cc\u06d2 \u067e\u0631\u062c\u0648\u0634 \u06c1\u06d2\u06d4<\/strong> \u062c\u0648 \u0627\u0646 \u0639\u0644\u0627\u062c \u06a9\u06cc \u062d\u06a9\u0645\u062a \u0639\u0645\u0644\u06cc\u0648\u06ba \u06a9\u0648 \u0644\u0627\u06af\u0648 \u06a9\u0631\u062a\u06d2 \u06c1\u06cc\u06ba\u06d4<\/p>\n

 <\/p>\n

-<\/p>\n

Erdos, MR, Cabral, WA, Tavarez, UL\u00a0\u0648\u063a\u06cc\u0631\u06c1<\/i>\u00a0\u06c1\u0686\u0646\u0633\u0646 \u2013 \u06af\u0644\u0641\u0648\u0631\u0688 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0633\u0646\u0688\u0631\u0648\u0645 \u06a9\u06d2 \u0644\u0626\u06d2 \u0627\u06cc\u06a9 \u0679\u0627\u0631\u06af\u0679\u0688 \u0627\u06cc\u0646\u0679\u06cc \u0633\u06cc\u0646\u0633 \u0639\u0644\u0627\u062c \u0645\u0639\u0627\u0644\u062c\u06c1\u06d4\u00a0\u0646\u06cc\u0679 \u0645\u06cc\u0688<\/i>\u00a0(2021)\u06d4 https:\/\/doi.org\/10.1038\/s41591-021-01274-0<\/p>\n

\u067e\u0679\u0627\u0631\u0627\u062c\u0648\u060c \u0627\u06cc\u0645\u060c \u062c\u06cc\u06a9\u0633\u0646\u060c \u0627\u06cc\u0645\u060c \u06a9\u0644\u06cc\u0646\u060c \u0627\u06cc\u0633\u06d4\u00a0\u0648\u063a\u06cc\u0631\u06c1<\/i>\u00a0\u0645\u0646\u0638\u0645 \u0627\u0633\u06a9\u0631\u06cc\u0646\u0646\u06af \u06c1\u0686\u0646\u0633\u0646 \u2013 \u06af\u0644\u0641\u0648\u0631\u0688 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0633\u0646\u0688\u0631\u0648\u0645 \u06a9\u06d2 \u0644\u0626\u06d2 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0627\u06cc\u0646\u0679\u06cc \u0633\u06cc\u0646\u0633 \u0627\u0648\u0644\u06cc\u06af\u0648\u0646\u0648\u06a9\u0644\u06cc\u0648\u0679\u0627\u0626\u0688\u0633 \u06a9\u06cc \u0634\u0646\u0627\u062e\u062a \u06a9\u0631\u062a\u06cc \u06c1\u06d2\u06d4\u00a0\u0646\u06cc\u0679 \u0645\u06cc\u0688<\/i>\u00a0(2021)\u06d4 https:\/\/doi.org\/10.1038\/s41591-021-01262-4<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

\u06c1\u0645 \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u06a9\u06cc \u062a\u062d\u0642\u06cc\u0642 \u0645\u06cc\u06ba RNA \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0627\u0633\u062a\u0639\u0645\u0627\u0644 \u06a9\u06d2 \u0628\u0627\u0631\u06d2 \u0645\u06cc\u06ba \u062f\u0648 \u0627\u0646\u062a\u06c1\u0627\u0626\u06cc \u062f\u0644\u0686\u0633\u067e \u067e\u06cc\u0634 \u0631\u0641\u062a \u06a9\u06d2 \u0645\u0637\u0627\u0644\u0639\u06d2 \u06a9\u06d2 \u0646\u062a\u0627\u0626\u062c \u06a9\u0627 \u0627\u0634\u062a\u0631\u0627\u06a9 \u06a9\u0631\u062a\u06d2 \u06c1\u0648\u0626\u06d2 \u0628\u06c1\u062a \u067e\u0631\u062c\u0648\u0634 \u06c1\u06cc\u06ba\u06d4 \u062f\u0648\u0646\u0648\u06ba \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u06a9\u0648 \u062f\u06cc \u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0631\u06cc\u0633\u0631\u0686 \u0641\u0627\u0624\u0646\u0688\u06cc\u0634\u0646 (PRF) \u06a9\u06d2 \u062a\u0639\u0627\u0648\u0646 \u0633\u06d2 \u0645\u0627\u0644\u06cc \u0627\u0639\u0627\u0646\u062a \u0641\u0631\u0627\u06c1\u0645 \u06a9\u06cc \u06af\u0626\u06cc \u062a\u06be\u06cc \u0627\u0648\u0631 PRF \u06a9\u06d2 \u0645\u06cc\u0688\u06cc\u06a9\u0644 \u0688\u0627\u0626\u0631\u06cc\u06a9\u0679\u0631 \u0688\u0627\u06a9\u0679\u0631 \u0644\u06cc\u0633\u0644\u06cc \u06af\u0648\u0631\u0688\u0646 \u0646\u06d2 \u0627\u0646 \u06a9\u06cc \u0645\u0634\u062a\u0631\u06a9\u06c1 \u062a\u0635\u0646\u06cc\u0641 \u06a9\u06cc \u062a\u06be\u06cc\u06d4 <\/p>","protected":false},"author":2,"featured_media":12414,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2,1],"tags":[],"class_list":["post-12401","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorized"],"yoast_head":"\nExciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation<\/title>\n<meta name=\"description\" content=\"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.progeriaresearch.org\/ur\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation\" \/>\n<meta property=\"og:description\" content=\"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.progeriaresearch.org\/ur\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\" \/>\n<meta property=\"og:site_name\" content=\"The Progeria Research Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ProgeriaResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-12T02:08:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-14T22:12:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"276\" \/>\n\t<meta property=\"og:image:height\" content=\"272\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karen Betournay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation\" \/>\n<meta name=\"twitter:description\" content=\"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@Progeria\" \/>\n<meta name=\"twitter:site\" content=\"@Progeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karen Betournay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u0645\u0646\u0679\u0633\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\"},\"author\":{\"name\":\"Karen Betournay\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946\"},\"headline\":\"Exciting breakthroughs in RNA Therapeutics for Progeria!\",\"datePublished\":\"2021-03-12T02:08:40+00:00\",\"dateModified\":\"2022-11-14T22:12:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\"},\"wordCount\":589,\"publisher\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg\",\"articleSection\":[\"News\",\"Uncategorized\"],\"inLanguage\":\"ur\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\",\"url\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\",\"name\":\"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg\",\"datePublished\":\"2021-03-12T02:08:40+00:00\",\"dateModified\":\"2022-11-14T22:12:14+00:00\",\"description\":\"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#breadcrumb\"},\"inLanguage\":\"ur\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ur\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage\",\"url\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg\",\"contentUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg\",\"width\":276,\"height\":272},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.progeriaresearch.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exciting breakthroughs in RNA Therapeutics for Progeria!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#website\",\"url\":\"https:\/\/www.progeriaresearch.org\/ta\/\",\"name\":\"The Progeria Research Foundation\",\"description\":\"For the Children \u2665 For the Cure\",\"publisher\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ur\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\",\"name\":\"The Progeria Research Foundation\",\"url\":\"https:\/\/www.progeriaresearch.org\/ta\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ur\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png\",\"contentUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png\",\"width\":300,\"height\":86,\"caption\":\"The Progeria Research Foundation\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ProgeriaResearch\/\",\"https:\/\/x.com\/Progeria\",\"https:\/\/www.instagram.com\/progeriaresearch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946\",\"name\":\"Karen Betournay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ur\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"caption\":\"Karen Betournay\"},\"url\":\"https:\/\/www.progeriaresearch.org\/ur\/author\/karenb\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation","description":"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.progeriaresearch.org\/ur\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/","og_locale":"en_US","og_type":"article","og_title":"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation","og_description":"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.","og_url":"https:\/\/www.progeriaresearch.org\/ur\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/","og_site_name":"The Progeria Research Foundation","article_publisher":"https:\/\/www.facebook.com\/ProgeriaResearch\/","article_published_time":"2021-03-12T02:08:40+00:00","article_modified_time":"2022-11-14T22:12:14+00:00","og_image":[{"width":276,"height":272,"url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg","type":"image\/jpeg"}],"author":"Karen Betournay","twitter_card":"summary_large_image","twitter_title":"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation","twitter_description":"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.","twitter_image":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg","twitter_creator":"@Progeria","twitter_site":"@Progeria","twitter_misc":{"Written by":"Karen Betournay","Est. reading time":"3 \u0645\u0646\u0679\u0633"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#article","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/"},"author":{"name":"Karen Betournay","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946"},"headline":"Exciting breakthroughs in RNA Therapeutics for Progeria!","datePublished":"2021-03-12T02:08:40+00:00","dateModified":"2022-11-14T22:12:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/"},"wordCount":589,"publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg","articleSection":["News","Uncategorized"],"inLanguage":"ur"},{"@type":"WebPage","@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/","url":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/","name":"Exciting breakthroughs in RNA Therapeutics for Progeria! | The Progeria Research Foundation","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg","datePublished":"2021-03-12T02:08:40+00:00","dateModified":"2022-11-14T22:12:14+00:00","description":"Two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research.\u00a0 Both studies were co-funded by The Progeria Research Foundation (PRF) and co-authored by PRF\u2019s Medical Director, Dr. Leslie Gordon.","breadcrumb":{"@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#breadcrumb"},"inLanguage":"ur","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/"]}]},{"@type":"ImageObject","inLanguage":"ur","@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#primaryimage","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2021\/03\/Carlos-with-crocheted-sloth-cropped.jpg","width":276,"height":272},{"@type":"BreadcrumbList","@id":"https:\/\/www.progeriaresearch.org\/ar\/2021\/03\/11\/exciting-breakthroughs-in-rna-therapeutics-for-progeria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.progeriaresearch.org\/"},{"@type":"ListItem","position":2,"name":"Exciting breakthroughs in RNA Therapeutics for Progeria!"}]},{"@type":"WebSite","@id":"https:\/\/www.progeriaresearch.org\/ta\/#website","url":"https:\/\/www.progeriaresearch.org\/ta\/","name":"\u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0631\u06cc\u0633\u0631\u0686 \u0641\u0627\u0624\u0646\u0688\u06cc\u0634\u0646","description":"\u0628\u0686\u0648\u06ba \u06a9\u06d2 \u0644\u06cc\u06d2 \u2665 \u0639\u0644\u0627\u062c \u06a9\u06d2 \u0644\u06cc\u06d2","publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ur"},{"@type":"Organization","@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization","name":"\u067e\u0631\u0648\u062c\u06cc\u0631\u06cc\u0627 \u0631\u06cc\u0633\u0631\u0686 \u0641\u0627\u0624\u0646\u0688\u06cc\u0634\u0646","url":"https:\/\/www.progeriaresearch.org\/ta\/","logo":{"@type":"ImageObject","inLanguage":"ur","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","width":300,"height":86,"caption":"The Progeria Research Foundation"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ProgeriaResearch\/","https:\/\/x.com\/Progeria","https:\/\/www.instagram.com\/progeriaresearch\/"]},{"@type":"Person","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946","name":"\u06a9\u06cc\u0631\u0646 \u0628\u06cc\u0679\u0648\u0631\u0646\u06d2","image":{"@type":"ImageObject","inLanguage":"ur","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","caption":"Karen Betournay"},"url":"https:\/\/www.progeriaresearch.org\/ur\/author\/karenb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/posts\/12401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/comments?post=12401"}],"version-history":[{"count":0,"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/posts\/12401\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/media\/12414"}],"wp:attachment":[{"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/media?parent=12401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/categories?post=12401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ur\/wp-json\/wp\/v2\/tags?post=12401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}